Tudor Investment Corp ET AL grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 79.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,703 shares of the pharmacy operator’s stock after purchasing an additional 30,369 shares during the period. Tudor Investment Corp ET AL’s holdings in Walgreens Boots Alliance were worth $5,380,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of WBA. Hudock Capital Group LLC raised its holdings in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the period. Reilly Financial Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the period. Private Vista LLC raised its holdings in shares of Walgreens Boots Alliance by 6,403.7% during the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after purchasing an additional 574,218 shares during the period. Hanson McClain Inc. increased its holdings in shares of Walgreens Boots Alliance by 4.6% in the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after acquiring an additional 87 shares during the period. Finally, Founders Capital Management acquired a new stake in shares of Walgreens Boots Alliance in the 1st quarter worth about $161,000. 63.35% of the stock is currently owned by institutional investors.

WBA has been the topic of a number of analyst reports. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, August 30th. Leerink Swann cut shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Thursday, October 26th. Finally, SunTrust Banks, Inc. set a $72.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Sunday, October 15th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $87.21.

In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $71.33 on Friday. The company has a market cap of $72,011.13, a PE ratio of 13.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.20. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance, Inc. has a 52 week low of $63.82 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $1.07 EPS. equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current year.

Walgreens Boots Alliance declared that its board has authorized a stock buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its stock is undervalued.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.24%. Walgreens Boots Alliance’s payout ratio is 42.33%.

TRADEMARK VIOLATION NOTICE: This report was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/11/24/walgreens-boots-alliance-inc-wba-shares-bought-by-tudor-investment-corp-et-al.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.